Searched for
PEPFAR FUNDING
The impact of Trump's foreign aid cuts, one year onHumanitarian efforts to fight diseases such as HIV, malaria and tuberculosis in some of the world's poorest nations have been massively dis...- US funding cuts could reverse decades of gains in AIDS fight: UNThe United Nations warns that the halt to US foreign aid, initiated by President Trump in February 2025, poses a significant threat to glob...
- US approves Gilead's twice-yearly injection to prevent HIVThe US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hail...
- Elon Musk and Bill Gates' feud gets ugly; Tesla CEO says, 'I wouldn’t want that guy to babysit my kids given that he frequented Jeffrey Epstein'Elon Musk got angry at Bill Gates for blaming him over aid cuts. Musk hit back by bringing up Gate’s past links to Epstein, and the two bil...
- Trump’s foreign aid freeze may put millions of children at HIV risk, warns Lancet reportA Lancet report warns that suspending or limiting funding to PEPFAR could lead to dire consequences in the African region. By 2030, one mil...
- Bill Gates warns White House he can't fill shortfalls in US global health fundingBill Gates has been actively lobbying Trump administration officials to maintain funding for global health programs, including childhood va...
- US Secretary of State Marco Rubio widens exemption for US aid after freezeUS Secretary of State Marco Rubio announced exemptions in the freeze on foreign assistance, continuing funding for humanitarian items like ...
- Cipla sees no major impact on biz from Donald Trump admin's decision to pause foreign aid: Umang VohraCipla, a drugmaker involved in supplying HIV medications through US-supported programmes, anticipates minimal impact from the Trump adminis...
- A US shutdown on foreign aid is hitting from Africa to Asia to Ukraine. Here's howU.S.-funded aid programs globally face halts and layoffs as a significant freeze on foreign assistance and domestic federal grants by the T...
- Laurus Labs shares nosedive 15% amid reports of US foreign aid suspensionLaurus Labs reported a 7% YoY drop in API revenues to Rs 531 crore for Q3 FY24, driven by lower ARV volumes. However, the FDF segment saw A...
- Big setback for Ukraine, Africa: US freezes almost all foreign aid except for Israel, Egypt armsThe United States, led by Secretary of State Marco Rubio under President Donald Trump's new "America First" policy, has frozen nearly all f...
- New HIV cases down by 44% since 2010: Anupriya PatelNew annual HIV infections in India have decreased by 44 per cent since 2010, surpassing the global reduction rate of 39 per cent. Union Min...
- Strides Pharma arm gets USFDA tentative nod for generic HIV treatment drugStrides Pharma Global, a subsidiary of Strides Pharma Science, has received tentative approval from the US FDA for its generic Dolutegravir...
- Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapyThrough the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic version...
- US offers $5 billion to fight HIV/AIDS"The United States of America will remain the global leader in the fight against HIV and AIDS," Obama said.
- Ranbaxy falls 6 pc in weak marketShares of domestic pharma major Ranbaxy Laboratories today touched a 52-week low of Rs 250.50 with analysts saying that it is the effect of...
- Stocks to watch: Tata Motors, Ranbaxy LabsThe outlook doesn’t look the least encouraging for Indian markets with Asian stocks falling for a fourth day after the US financial rescue ...
- Now, US won't source AIDS drugs from RanbaxyUS government will not source drugs under its global AIDS drug supply programme from Ranbaxy plants in India. Top food myths| Successful bi...
- Ranbaxy drugs in US AIDS programme under scannerThe development follows the US Food and Drug Administration’s (USFDA) ban on Ranbaxy’s 30 generic drugs and seven APIs.
- Indian firms get lion's share in US anti-AIDS fundingAurobindo Pharma, Cipla and Ranbaxy, have received a lion's share of over 85 per cent in the US government's latest fiscal funding for AIDS...
Load More
